Myth
Hantavirus is the new COVID-19.
Fact
The Andes virus has limited human-to-human transmission and requires very close, prolonged contact. The WHO classifies the global risk of the MV Hondius cluster as 'low'.
Editorial guide updated with official information from WHO (DON599), CDC (HAN00528) and ECDC. Twelve verified answers, comparison with COVID-19/flu/Ebola, debunked myths and primary sources cited. If you're wondering whether this could become a pandemic, start here.
Quick summary
Hantavirus isn't one — it's a family of viruses. The MV Hondius outbreak is the Andes variant, native to South America.
High case fatality (30-40% in severe cases) but low human-to-human transmissibility: requires very close, prolonged contact.
Not comparable to COVID-19. R₀ < 1, no sustained transmission. WHO and CDC classify global risk as 'low'.
No Western-approved vaccine and no effective specific antiviral. Treatment is early intensive support, which does save lives.
42-day quarantine matching the maximum incubation period. Active surveillance through June 21, 2026.
Current status
Official WHO (DON599) + CDC (HAN00528) figures. Updated through completed disembarkation.
Comparison
Consolidated data from WHO fact sheets, CDC and reviews published in NEJM and The Lancet.
R₀ (range)
0 — 5
Case fatality
0 — 100 %
| Metric | Hantavirus (Andes) | COVID-19 | Seasonal flu | Ebola (Zaire) |
|---|---|---|---|---|
| Main transmission | Rodent excreta aerosols · rarely person-to-person | Respiratory aerosols · high | Respiratory aerosols · high | Body fluids · direct contact |
| R₀ (range) | < 1 (not sustained) | 2.5 – 3.5 (Wuhan) | 1.2 – 1.4 (seasonal) | 1.5 – 2.5 (outbreaks) |
| Case fatality | 30 – 40% (HPS) | ~ 0.5 – 1% (Omicron) | < 0.1% (seasonal) | 25 – 90% (strain-dependent) |
| Vaccine available | No (Western) | Yes · multiple platforms | Yes · seasonal | Yes (rVSV-ZEBOV, Zaire) |
| Specific treatment | No · intensive support | Antivirals (Paxlovid, etc.) | Antivirals (oseltamivir) | Monoclonal antibodies |
| Incubation period | 7 – 42 days | 2 – 14 days | 1 – 4 days | 2 – 21 days |
| Natural reservoir | Wild rodents | Bats (likely) | Aquatic birds | Fruit bats |
Public health risk isn't measured by probability alone — it's measured by probability × consequence.
FAQ
Hantavirus is not a single virus — it's a group of viruses in the Hantaviridae family. Some circulate in the Americas, others in Europe and Asia. In the Americas they cause mainly hantavirus pulmonary syndrome (HPS), a severe respiratory illness. In Eurasia they cause hemorrhagic fever with renal syndrome (HFRS), with kidney damage.
Mainly via contact with urine, droppings or saliva of infected wild rodents — especially when those particles aerosolize when dry-sweeping a poorly ventilated space and are inhaled. It does not spread easily between people. The exception is the Andes virus (South America), the only species with documented human-to-human transmission, and only under very close and prolonged contact.
No. COVID-19 spreads efficiently between people, even asymptomatic ones, via respiratory aerosols. Hantavirus —even the Andes variant with human-to-human transmission— requires very close and prolonged physical contact. That's why the WHO keeps the MV Hondius cluster's global risk as "low".
No Western-approved vaccine and no effective specific antiviral exist. Ribavirin, evaluated for hantavirus, did not show efficacy in HPS. Treatment is early intensive support: oxygen, mechanical ventilation if the cardiopulmonary phase requires it, hemodynamic control and ICU monitoring. Early diagnosis makes the difference.
Non-specific initial phase: fever, muscle pain, headache, malaise, sometimes diarrhea or vomiting. After 4–10 days, breathing difficulty, hypotension and pulmonary edema may appear (cardiopulmonary phase). If you have those initial symptoms without rodent exposure or any link to the MV Hondius cluster, it is much more likely to be something else.
Usually around 2 weeks, but can range from 7 days to 6 weeks (42 days). That's why authorities are monitoring MV Hondius exposed individuals for six weeks from disembarkation ("day zero" = May 10, 2026 → end of surveillance = June 21, 2026).
Reduce contact with wild rodents and their excreta. Never dry-sweep or vacuum droppings — ventilate first, spray with diluted bleach, wait 10 minutes, clean with gloves. Seal cracks to keep rodents out. In cabins, sheds or rural areas: check before entering, ventilate, do not sleep on the floor and store food in sealed containers.
It's the hantavirus species circulating in Argentina and Chile, associated with the long-tailed colilargo mouse (Oligoryzomys longicaudatus). It's the only species with documented human-to-human transmission, although only in very close contacts. The natural reservoir is NOT present in Europe, so the ECDC rules out the virus establishing itself in European rodents even if there were secondary transmission.
Case fatality measures how many die among those who get sick. Hantavirus can have high case fatality —up to 40% in some outbreaks— in patients with severe HPS. Mortality measures deaths within the total population: since infection is rare, the population impact is very low. Something can be highly lethal for the patient and still not pose a mass threat.
Unlikely on current evidence. A 2021 systematic review found no strong evidence of sustained human-to-human transmission of hantavirus in general. Andes virus has shown interpersonal transmission in isolated Argentine and Chilean outbreaks, but always limited. More cases may appear among MV Hondius exposed individuals due to the long incubation, but a wide community epidemic doesn't fit the virus's biology.
"Contact" is someone who was near a case (all MV Hondius passengers are contacts by precaution, not because they are infected). "Suspected" has compatible symptoms but no lab confirmation. "Confirmed" has positive PCR. "Deceased" is the fatal outcome. Banner figures mix confirmed + suspected for transparency, not clinical equivalence.
Because in public health risk is not measured only by probability, but by probability × consequence. The probability of transmission is low, but the consequence (high case fatality in severe cases) is severe. That justifies 42-day quarantine, contact tracing, mandatory crew PCR and strict isolation, even though the risk to the general population remains low.
Myths vs facts
The claims circulating on social media and the data that debunks them.
Myth
Hantavirus is the new COVID-19.
Fact
The Andes virus has limited human-to-human transmission and requires very close, prolonged contact. The WHO classifies the global risk of the MV Hondius cluster as 'low'.
Myth
City rats transmit it.
Fact
Reservoirs are specific wild rodents by region. The Andes virus is linked to the long-tailed colilargo mouse (Oligoryzomys longicaudatus) from South America — the ECDC rules out it taking hold in European rodents.
Myth
If the ship had cases, all passengers are infected.
Fact
Contact ≠ infection. Out of caution, all passengers are treated as contacts, but only 9 confirmed (out of 147 onboard) are active cases.
Myth
If there's no specific treatment, there's nothing to do.
Fact
Early intensive support (oxygen, ventilation, hemodynamic control) saves lives. The difference between catching it early and late can be dramatic.
Myth
If I quickly clean up mouse droppings, nothing happens.
Fact
Dry-sweeping or vacuuming aerosolizes viral particles — that's the main exposure route. Ventilate first, spray with 10% bleach, wait 10 minutes, clean with gloves.
Myth
The 42-day quarantine is excessive.
Fact
The maximum incubation period of the Andes virus is 6 weeks. Shortening it would leave cases undetected. It's the same criterion the WHO has applied since previous Argentine and Chilean outbreaks.
Sources
Unofficial source. Information aggregated from public reports. Not a substitute for medical advice or official sources (WHO, CDC, ministries of health).